Cancer
Our cancer research examines many of the most prevalent cancers today with the goal of finding new and innovative therapies, treatments and ultimately prevention and cures.
Our researchers discovered a link between finasteride, a medication used to relieve urinary problems, and prevention of prostate cancer.
The Mays Cancer Center is a member of The Pediatric Oncology Experimental Therapeutics Investigators' Consortium (POETIC).
Clinical trial participation is an invaluable way to contribute to the pursuit of new treatments for cancer. Take action today! Volunteer and play a role in finding a cure.
Find
Home to the only National Cancer Institute-designated cancer center in South Texas, UT Health San Antonio MD Anderson Cancer Center conducts more than 200 clinical trials in over 30 types of cancers.
Additional Highlights
-
Dr. Mingjiang Xu receives UT System award to support cancer epigenetics research
Mingjiang Xu, MD, PhD, professor of molecular medicine, was awarded a $1 million UT System Faculty STARs award to enhance cancer epigenetics research and support the discovery of targeted therapeutics for blood cancers.
Read the full story in the Newsroom -
New insights about COVID-19 treatments for cancer patients
The COVID-19 and Cancer Consortium (CCC19), which includes the Mays Cancer Center, home to UT Health San Antonio MD Anderson, announced results July 22 of its second national observational study. The study compares the outcomes of cancer patients diagnosed with COVID-19 to the treatments they received.
Read the article at UT Health San Antonio's Newsroom -
Cancer drugs cause large cells that resist treatments; scientist aims to stop it
Daruka Mahadevan, MD, Ph.D., professor and chief of the Division of Hematology-Oncology in the Long School of Medicine, has studied this progression for 20 years. In a paper published in April 2020 in the journal Trends in Cancer, he and co-author Gregory C. Rogers, Ph.D., explain a rationale for stopping it.
Learn more at UT Health San Antonio's Newsroom -
Mays Cancer Center awarded millions for research and recruitment
The Cancer Prevention and Research Institute of Texas awarded more than $10.3 million Aug. 19 to the Mays Cancer Center, home to UT Health San Antonio MD Anderson. The five grants include $6 million to recruit David Gius, MD, PhD, a breast cancer and radiation oncology researcher from the Robert H. Lurie Comprehensive Cancer Center at Northwestern University.
Read the article at UT Health San Antonio's Newsroom